Guardant Health, Inc. (GH): debt financing — Guardant Health raises ~$717M via upsized equity and convertible debt offerings

Guardant Health, Inc.

Public offering of 3,833,332 shares at $90/share (incl. underwriter option), net proceeds ~$327.2M.
Convertible notes: $402.5M principal, 0% coupon, due 2033, conversion price ~$121.50/share (35% premium).
Net proceeds from notes ~$390M; combined ~$717M for general corporate purposes, including possible 2027 note repurchase.
Both offerings upsized from initially announced amounts ($250M equity, $300M notes); closed Nov 7, 2025.
Notes convertible under certain conditions after Feb 15, 2033; redeemable after Nov 20, 2029.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Guardant Health, Inc. incurred convertible notes of $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033 with U.S. Bank Trust Company, National Association at 0.00% maturing May 15, 2033.

Instrument: convertible notes
Principal: $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033
Counterparty: U.S. Bank Trust Company, National Association
Rate: 0.00%
Maturity: May 15, 2033
Event: incurrence

Exact text from the filing

On November 7, 2025, the Company completed its previously announced private offering (the “Convertible Notes Offering”) of $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $52.5 million principal amount of Notes.

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Guardant Health, Inc. issued convertible note to initial purchasers for $402.5 million aggregate principal amount.

Security: convertible note
Purchaser: initial purchasers
Consideration: $402.5 million aggregate principal amount

Exact text from the filing

On November 7, 2025, the Company completed its previously announced private offering (the “Convertible Notes Offering”) of $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $52.5 million principal amount of Notes.

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Guardant Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-272592

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.